Navigation Links
Slowing evolution to stop drug resistance
Date:11/16/2009

/B>

"We stimulate the evolution of the yeast cell and observe it in real time. As our yeasts develop resistance to a particular drug, we measure how the survivability of the different strains changes during the process. Evolution progresses more slowly in some strains when a specific component is destroyed. These strains are like gold dust to us, because they tell us that these particular components are critical to the speed of evolution," says Jonas Warringer.

"This is how we eventually found the genes that regulate evolution. If, in the next phase, we can find a substance that can attack one of these components, we will be able to delay the development of drug resistance and ensure that today's drugs remain effective into the future."

The research project is funded by the Magnus Bergwall Foundation and other benefactors. Jonas Warringer hopes that evolution-slowing drugs will become available within the next 10-15 years.


'/>"/>

Contact: Jonas Warringer
jonas.warringer@cmb.gu.se
46-031-786-3961
University of Gothenburg
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Landscape-scale treatment promising for slowing beetle spread
2. Researchers combat slowing yields with targeted fertilizer applications
3. Biologists, educators recognize excellence in evolution education
4. Study sheds light on evolution of human complexity
5. Evolution of hyperactivity is focus of free public lecture at UC Riverside
6. K-State receives more than $780,000 to fund graduate students studying ecology, evolution, genomics
7. Time in a bottle: Scientists watch evolution unfold
8. Science wins fight over evolution in schools, says Case Western Reserve University author
9. The amazing maze of maize evolution
10. Genetic conflict in fish led to evolution of new sex chromosomes
11. Frozen assets: NIAID researchers turn to unique resource for clues to norovirus evolution
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Slowing evolution to stop drug resistance
(Date:9/2/2014)... Human Genetics (ASHG) and the National Human Genome ... of Health, have named Elizabeth P. Tuck, MA, ... in Columbus, Ohio, the first ASHG/NHGRI Genetics and ... The Genetics and Education Fellowship is intended to ... and network to prepare for a career in ...
(Date:9/2/2014)... -- A team of University of Maryland physicists ... other scientists say make possible new nanostructures and ... energy and quantum computing advances to new sensor ... of Nature Communications the Maryland scientists, ... for hybrid nanostructures that uses a connector, or ...
(Date:9/2/2014)... new study that could ultimately lead to many new ... Research Institute (TSRI) have adapted a chemical approach to ... that can treat a form of muscular dystrophy. , ... a disease-causing defect as a catalyst to synthesize a ... Disney.,"Because the treatment is synthesized only in diseased cells, ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2New synthesis method may shape future of nanostructures, clean energy 2New synthesis method may shape future of nanostructures, clean energy 3Scripps Florida scientists make diseased cells synthesize their own drug 2
... More atomic hydrogen gas the ultimate fuel for stars ... astronomer Dr Robert Braun has found.,This is the first accurate ... Just after the Big Bang the Universe,s matter was ... came together and generated galaxies, stars and planets and ...
... Agricultural Research and Development, have evaluated the effect of ... in sheep flocks. This disease mainly causes abortions, although ... and weakness in newborn lambs. The control of this ... it spreads easily among the animals and causes significant ...
... be held in Copenhagen, Denmark, on 4-5 June, ... the GMES Global Monitoring for Environment and Security ... User testimonials of pre-operational services, prospects for increased ... assessments will form the core of the conference ...
Cached Biology News:There's more star-stuff out there but it's not dark matter 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 3
(Date:9/2/2014)... overlooked factor in the medical application of nanoparticles. ... on both radiofrequency heating and magnetic resonance image ... including detailed analysis of the aggregate morphologies based ... produce significant reductions in both heating and MRI ... quantify and correlate these effects for clinical applications, ...
(Date:9/2/2014)... 2, 2014 Persistence Market Research ... in Pharmaceutical, Biopharma and Life Sciences: North ... the global membrane technology market for pharmaceutical, biopharma and life sciences ... is expected to grow at a CAGR of 9.1% ... of USD 10,886.0 million in 2019. Browse ...
(Date:9/2/2014)... Sept. 2, 2014 Orexigen Therapeutics, Inc. (Nasdaq: ... Patent and Trademark Office (PTO) has issued a patent ... for weight loss. NB32 is a fixed-dose combination of ... U.S. Patent No. 8,815,889 claims methods for treating insulin ... patent expires in 2024. If NB32 is approved for ...
(Date:9/2/2014)... Mount, NC (PRWEB) September 02, 2014 ... establishment of its 11th clinical research site: PMG Research ... assumed ownership and operation of the clinical research department ... further expanding PMG’s presence in eastern North Carolina. This ... patients. For the patients in Rocky Mount and the ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3
... Wis . - Can a heart patient's own stem cells be ... School of Medicine and Public Health intends to find out ... Hospital and Clinics . , ,The school is among the first ... which will investigate whether a person's own stem cells can treat ...
... - Deltanoid Pharmaceuticals , a privately held pharmaceutical ... clinical study of 2MD, its lead osteoporosis compound. , ... can safely improve bone mineral density in postmenopausal women. ... bone that results in susceptibility to fractures, occurs frequently ...
... - In a recent report that probably went ... University Technology Managers released figures that show why ... Wisconsin is a hotbed for scientific research. The numbers ... professors working in labs; it's about creating jobs for ...
Cached Biology Technology:UW tests adult stem cell role in regenerative heart care 2Tapping hidden assets: Wisconsin researchers who can create jobs 2Tapping hidden assets: Wisconsin researchers who can create jobs 3Tapping hidden assets: Wisconsin researchers who can create jobs 4
... is a simple, easy to use ... bacterial and yeast applications. The ... voltages and either one mm, two ... pressing the pulse button the electroporator ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
MOUSE ANTI GTP BINDING PROTEIN...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: